Two herbal cognitive supplements with decades of use. One has landmark negative trials, one has consistent positive data. Here's the split.
Two supplements that both raise brain energy — through different pathways. Here's when to pick each, and why they might work best together.
Cognizin costs 2-3x more than generic citicoline. Is the branded, patented form worth it? Here's what the trial data actually says.
L-threonate crosses the blood-brain barrier. Glycinate is the best-absorbed form for sleep. Here's when each earns its price.
Bacopa monnieri and Lion's Mane both improve cognition without stimulant edge — but through different mechanisms. Here's which one fits which goal.
Two of the most-studied adaptogens compared: KSM-66 ashwagandha vs SHR-5 rhodiola. Different mechanisms, different symptom profiles.
Lion's Mane has buzz. Citicoline has data. We compare both nootropics head-to-head on mechanisms, clinical evidence, and which to choose for brain health.
The best brain-protective foods backed by research, how much you'd need to eat to match supplement doses, and when supplementation actually makes sense.
DHA is the dominant structural fat in your brain — and your levels drop as you age. Here's what the science says about how it protects cognition and why older adults need more.
Citicoline is one of the most studied nootropics for attention and memory. Here's what clinical trials actually found — including the doses, timelines, and populations tested.
How to build an evidence-based brain supplement stack. The core pairing, when to expand, and what to skip. Practical protocol with doses and timing.
The best brain supplements of 2026 ranked by clinical evidence. Citicoline, Omega-3, Bacopa, Creatine & more reviewed against meta-analyses and RCTs. No hype, just science.
The best citicoline (CDP-choline) supplements of 2026. Cognizin vs generic, dosing guide, what to look for, and our top picks based on clinical evidence.
Best brain supplements for adults over 60 ranked by clinical evidence in older populations. Safety, drug interactions, and age-specific research prioritized.